HOME >> BIOLOGY >> NEWS
DNA test solving Chesapeake's toxic mysteries

As the summer heats up Chesapeake Bay waters, a new kind of test to detect toxic marine microbes is sharpening Maryland efforts to predict fish-killing Pfiesteria. The test also helps medical studies of illness associated with the microbe.

David Oldach of the University of Maryland Biotechnology Institute (UMBI) reports that the test, applied to samples of mud or water, rapidly identifies Pfiesteria piscicida. In 1997, the microbe was linked with major fish kills in three Maryland rivers as well as previous fish kills in North Carolina. In addition, watermen near the fish kills and laboratory workers handling Pfiesteria cultures have suffered from illness ranging from skin lesions and stomach cramps to temporary memory loss and learning impairment lasting up to seven weeks.

In a recent issue of the Proceedings of the National Academy of Sciences, Oldach writes that the test is based on a "time-tested molecular biology method used commonly in medical research." The method, called HMA, is more often used to tease ut different strains of viruses in studies of Hepatitis C, AIDS, or gene mutations linked with cancer, or genetic diseases, such as cystic fibrosis.

Oldach and colleagues at UMBI's Institute of Human Virology (IHV) applied the method to samples of water and cultures of Pfiesteria-like microbes from Maine, Maryland, and North Carolina. The result is a DNA fingerprint of Pfiesteria used in the new test. The test can be adapted to detect other toxic marine organisms, he adds.

Last year in Maryland, experiments on the new test helped show that P. piscicida existed in at least 14 rivers and increased dramatically in July and August, according to Dave Goshorn, chief of the Maryland Department of Natural Resources' (DNR) Living Resource Assessment Program. "We found that the new test works so well, we will expand from 50 to 100 testing sites in the Bay area in 2000, in addition to any fish kill sites."

The new Pfiesteria test i
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
30-Jul-2000


Page: 1 2 3

Related biology news :

1. Carnegie Mellon scientists reveal ways of studying, resolving PCB contamination in US rivers
2. Imaging the brain solving problems through insight
3. Saint Louis University researchers make breakthrough towards solving the cause of cancer development
4. Chemistry to play major role in solving 21st century challenges
5. Resolving Conflicts -- What We Can Learn From The Apes
6. Rice finds on-off switch for buckyball toxicity
7. Prion propagation: Avoiding the toxic oligomer
8. Byproduct of water-disinfection process found to be highly toxic
9. Stem cells more vulnerable to toxic chemotherapy when protective molecule is disabled
10. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides
11. JGI decodes wood & toxic waste-degrading fungus genome

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA test solving Chesapeake toxic mysteries

(Date:6/23/2015)... GARDENS, Fla. , June 23, 2015 ... identity management and authentication solutions, today announced enhanced ... strong, multi-factor authentication solution.  The enhancements build ... use of the DigitalPersona Altus platform and ... reader compatibility. In today,s environment ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 /PRNewswire/ ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt ... ; Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die ... neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte ...
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
(Date:7/2/2015)... ... July 02, 2015 , ... ... of surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, ... largest provider of surgical instruments to the Spine Industry. The acquisition of Turner ...
(Date:7/1/2015)... BURLINGTON, Mass. , July 1, 2015 /PRNewswire/ ... three most frequently cited advantages of Otezla are ... favorable safety profile, as reported by surveyed rheumatologists. ... and launched for the treatment of active psoriatic ... . The current standard of care includes conventional ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: